111 related articles for article (PubMed ID: 6771337)
1. Antibody-dependent cell-mediated antibacterial activity of human mononuclear cells. II. Immune specificity of antimeningococcal activity.
Smith LF; Lowell GH
J Infect Dis; 1980 Jun; 141(6):748-51. PubMed ID: 6771337
[TBL] [Abstract][Full Text] [Related]
2. Antibody-dependent cell-mediated antibacterial activity of human mononuclear cells. I. K lymphocytes and monocytes are effective against meningococi in cooperation with human imune sera.
Lowell GH; Smith LF; Artenstein MS; Nash GS; MacDermott RP
J Exp Med; 1979 Jul; 150(1):127-37. PubMed ID: 109572
[TBL] [Abstract][Full Text] [Related]
3. Antibody-dependent mononuclear cell-mediated antimeningococcal activity. Comparison of the effects of convalescent and postimmunization immunoglobulins G, M, and A.
Lowell GH; Smith LF; Griffiss JM; Brandt BL; MacDermott RP
J Clin Invest; 1980 Aug; 66(2):260-7. PubMed ID: 6772670
[TBL] [Abstract][Full Text] [Related]
4. Specificity of antibodies to O-acetyl-positive and O-acetyl-negative group C meningococcal polysaccharides in sera from vaccinees and carriers.
Arakere G; Frasch CE
Infect Immun; 1991 Dec; 59(12):4349-56. PubMed ID: 1937795
[TBL] [Abstract][Full Text] [Related]
5. [Evaluation of the level of antibodies to purified meningococcal antigens].
Kuznetsova EM; Borisenko IuV; Tsvetkova NV
Zh Mikrobiol Epidemiol Immunobiol; 1988 Jan; (1):65-8. PubMed ID: 3129887
[TBL] [Abstract][Full Text] [Related]
6. Immunization of humans with polysaccharide vaccines induces systemic, predominantly polymeric IgA2-subclass antibody responses.
Tarkowski A; Lue C; Moldoveanu Z; Kiyono H; McGhee JR; Mestecky J
J Immunol; 1990 May; 144(10):3770-8. PubMed ID: 2110213
[TBL] [Abstract][Full Text] [Related]
7. Immunization with recombinant Chaperonin60 (Chp60) outer membrane protein induces a bactericidal antibody response against Neisseria meningitidis.
Phillips R; Williams JN; Tan WM; Bielecka MK; Thompson H; Hung MC; Heckels JE; Christodoulides M
Vaccine; 2013 May; 31(22):2584-90. PubMed ID: 23566947
[TBL] [Abstract][Full Text] [Related]
8. IgA-dependent, monocyte-mediated, antibacterial activity.
Lowell GH; Smith LF; Griffiss JM; Brandt BL
J Exp Med; 1980 Aug; 152(2):452-7. PubMed ID: 6156988
[TBL] [Abstract][Full Text] [Related]
9. Antibodies to meningococcal class 1 outer-membrane protein and its variable regions in patients with systemic meningococcal disease.
Idänpään-Heikkilä I; Høiby EA; Chattopadhyay P; Airaksinen U; Michaelsen TM; Wedege E
J Med Microbiol; 1995 Nov; 43(5):335-43. PubMed ID: 7562997
[TBL] [Abstract][Full Text] [Related]
10. [Level of IgG antibodies to bacteria of 12 species in the blood sera of rabbits, immunized with preparations obtained from Neisseria meningitidis, grown under the stress conditions].
Basnak'ian IA; Aleksakhina NN; Iastrebova NE; Vaneeva NP
Zh Mikrobiol Epidemiol Immunobiol; 2005; (5):14-9. PubMed ID: 16279527
[TBL] [Abstract][Full Text] [Related]
11. Cellular immunity in patients with meningococcal disease and in vaccinated subjects.
Greenwood BM; Oduloju AJ; Ade-Serrano MA
Clin Exp Immunol; 1979 Oct; 38(1):9-15. PubMed ID: 118835
[TBL] [Abstract][Full Text] [Related]
12. Antiidiotype antibodies as surrogates for polysaccharide vaccines.
Westerink MA; Campagnari AA; Giardina P; Apicella MA
Ann N Y Acad Sci; 1994 Aug; 730():209-16. PubMed ID: 8080172
[TBL] [Abstract][Full Text] [Related]
13. [The bactericidal action of human neutrophils on meningococci in vitro].
Platonov AE; Vershinina IV; Käyhty H; Fijen CA; Kuijper EJ
Zh Mikrobiol Epidemiol Immunobiol; 1999; (3):46-52. PubMed ID: 10851990
[TBL] [Abstract][Full Text] [Related]
14. Functional opsonic activity of human serum antibodies to inner core lipopolysaccharide (galE) of serogroup B meningococci measured by flow cytometry.
Plested JS; Ferry BL; Coull PA; Makepeace K; Lehmann AK; MacKinnon FG; Griffiths HG; Herbert MA; Richards JC; Moxon ER
Infect Immun; 2001 May; 69(5):3203-13. PubMed ID: 11292742
[TBL] [Abstract][Full Text] [Related]
15. [Antibody response to capsular polysaccharide antigen in an infection caused by meningococcus serogroup B in children].
Kostiukova NN; Basnak'ian IA; Aleksakhina NN; Borovkova VM; Derkach SA
Zh Mikrobiol Epidemiol Immunobiol; 1987 Jul; (7):49-53. PubMed ID: 2445133
[TBL] [Abstract][Full Text] [Related]
16. Specificity of the immune response to a modified group B meningococcal polysaccharide conjugate vaccine.
Moore S; Farley EK; Fusco PC; Michon F
Clin Vaccine Immunol; 2007 Jan; 14(1):106-9. PubMed ID: 17079431
[TBL] [Abstract][Full Text] [Related]
17. [Evaluation of the immunogenicity of meningococcal vaccines in experiments on mice].
Krasnoproshina LI; Ermakova LG; Belova TN; Efimov DL; Filippov IuV
Zh Mikrobiol Epidemiol Immunobiol; 1979 Jul; (7):59-62. PubMed ID: 112808
[TBL] [Abstract][Full Text] [Related]
18. Candidacy of LPS-based glycoconjugates to prevent invasive meningococcal disease: developmental chemistry and investigation of immunological responses following immunization of mice and rabbits.
Cox AD; Zou W; Gidney MA; Lacelle S; Plested JS; Makepeace K; Wright JC; Coull PA; Moxon ER; Richards JC
Vaccine; 2005 Oct; 23(43):5045-54. PubMed ID: 16046037
[TBL] [Abstract][Full Text] [Related]
19. Putative vaccine antigens from Neisseria meningitidis recognized by serum antibodies of young children convalescing after meningococcal disease.
Litt DJ; Savino S; Beddek A; Comanducci M; Sandiford C; Stevens J; Levin M; Ison C; Pizza M; Rappuoli R; Kroll JS
J Infect Dis; 2004 Oct; 190(8):1488-97. PubMed ID: 15378443
[TBL] [Abstract][Full Text] [Related]
20. Human immunity to the meningococcus. I. The role of humoral antibodies.
Goldschneider I; Gotschlich EC; Artenstein MS
J Exp Med; 1969 Jun; 129(6):1307-26. PubMed ID: 4977280
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
